Increased oxidative stress in patients with hydatidiform mole

被引:0
|
作者
Harma, M
Harma, M
Erel, O
机构
[1] Univ Harran, Fac Med, Dept Gynaecol, Sanliurfa, Turkey
[2] Univ Harran, Fac Med, Dept Obstet, Sanliurfa, Turkey
[3] Univ Harran, Fac Med, Dept Biochem, Sanliurfa, Turkey
关键词
antioxidant; total antioxidant; total antioxidant potential; total peroxide; hydatidiform mole; pregnancy;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim of this study was to determine the oxidative status and antioxidative status of plasma of patients with complete hydatidiform mole (CHM) and to compare these values with normal pregnancy. Method: Thirty-eight patients with CHM and 31 healthy pregnant women were enrolled in the study. To determine the antioxidative status of plasma, total antioxidant potential (TAOP) was calculated, and to determine the oxidative status of plasma total peroxide levels were measured. The ratio of TAOP to total peroxide was accepted as an indicator of oxidative stress. Results: TAOP of plasma was significantly lower in patients with hydatidiform mole than in healthy pregnant women [mean (SD) values were 511.9 (105.8) and 571.7 (109.4) mumol Trolox equiv./L respectively (p <0.05)]. In contrast, mean (SD) total peroxide level of plasma was significantly higher in the patients [21.8 (6.4) mumol H2O2/L] than in healthy pregnant women [15.6 (6.4) pmol H2O2/L (p <0.001)]. The mean oxidative stress index level was significantly higher in patients with CUM than in healthy pregnant women [4.43 (1.70) versus 2.92 (1.50) respectively (p <0.001)]. Conclusion: Patients with CHM are exposed to oxidative stress, which may have a role in the pathogenesis of the disease. Supplementation with antioxidative vitamins such as C and E could be considered in treatment.
引用
收藏
页码:563 / 566
页数:4
相关论文
共 50 条
  • [31] Hydatidiform mole and hyperthyroidism
    Alves, Marta
    Neves, Celestino
    Carvalho-Braga, Daniel
    Medina, Jose Luis
    ENDOCRINE JOURNAL, 2010, 57 : S471 - S471
  • [32] TUBAL HYDATIDIFORM MOLE
    DEPYPERE, HT
    DHONT, M
    VERSCHRAEGENSPAE, MR
    COPPENS, M
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (01) : 209 - 210
  • [33] IMMUNOGENICITY OF HYDATIDIFORM MOLE
    LAWLER, SD
    FISHER, RA
    PLACENTA, 1987, 8 (02) : 195 - 199
  • [34] Complete hydatidiform mole
    Candelier, Jean-Jacques
    M S-MEDECINE SCIENCES, 2015, 31 (10): : 863 - 870
  • [35] RECURRENT HYDATIDIFORM MOLE
    JOHNSON, FL
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1966, 94 (07) : 344 - &
  • [36] THE TREATMENT OF HYDATIDIFORM MOLE
    HUNTER, JS
    SURGICAL CLINICS OF NORTH AMERICA, 1959, 39 (04) : 1131 - 1136
  • [37] INVASIVE HYDATIDIFORM MOLE
    JONES, OV
    EVANS, G
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY OF THE BRITISH EMPIRE, 1949, 56 (04): : 660 - 662
  • [38] HYDATIDIFORM MOLE AND HYPERTHYROIDISM
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1971, 2 (5762): : 606 - +
  • [39] DIAGNOSIS OF HYDATIDIFORM MOLE
    ACOSTASISON, H
    OBSTETRICS AND GYNECOLOGY, 1958, 12 (02): : 205 - 208
  • [40] Complete Hydatidiform Mole
    Liu, Yuanwei
    Hao, Peipei
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (18): : 1708 - 1708